Written answers
Tuesday, 8 April 2025
Department of Health
Health Services
Joe Cooney (Clare, Fine Gael)
Link to this: Individually | In context | Oireachtas source
897. To ask the Minister for Health when free HRT will be made available; if there are plans to refund those people who have paid for medicines since the beginning of the year; and if she will make a statement on the matter. [16725/25]
Albert Dolan (Galway East, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
904. To ask the Minister for Health the reason for the delay in the implementation of the free hormone replacement therapy scheme, which was originally scheduled to begin in January 2025; if a revised timeline for its rollout is now in place; and if she will make a statement on the matter. [16764/25]
Brian Stanley (Laois, Independent)
Link to this: Individually | In context | Oireachtas source
960. To ask the Minister for Health the timeline for the provision of free hormone replacement therapy, given the commitment given in Budget 2025 for same; the reason for the delay with the pharmacists; and when women will be able to avail of this free therapy; and the date to resolve the issue (details supplied). [17035/25]
Maeve O'Connell (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source
983. To ask the Minister for Health to report on the delivery of free HRT products-medication; and if she will make a statement on the matter. [17303/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 897, 904, 960 and 983 together.
As Minister for Health, I am committed to the implementation of the Hormone Replacement Therapy (HRT) measure announced in Budget 2025 and reaffirmed in the new Programme for Government: Securing Ireland's Future.
My Department and the Health Service Executive (HSE) has engaged extensively with the Irish Pharmacy Union in relation to the practical rollout of this measure.
When operational, this measure will cover any HRT medications and products which are reimbursable by the HSE, which have been prescribed for the purposes of alleviating the symptoms of menopause.
Reimbursement support for this new HRT measure will be available to participating pharmacies from the date the measure formally commences.
I am actively engaged on the matter with the goal to introduce this measure as soon as possible.
No comments